Not everyone reacts to vaccines in the same way. Immune responses vary in strength depending on age, sex, prior illnesses and genetics.
In a new study, published in the Cell Press Blue journal, researchers at the United States National Cancer Institute’s SeroNet program investigated how pre-existing antibodies to common microbes can predict a person’s response to new vaccines.